Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

A 12 month smoking cessation outcome-Allen Carr’s Easyway to Stop Smoking-a randomised clinical trial

Sheila Keogan, Shasha Li, Luke Clancy
European Respiratory Journal 2018 52: OA5227; DOI: 10.1183/13993003.congress-2018.OA5227
Sheila Keogan
1TFRI, Dublin, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shasha Li
1TFRI, Dublin, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luke Clancy
1TFRI, Dublin, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Background/Aims: Allen Carr’s Easyway to Stop Smoking (AC) is widely used. There are no published randomised clinical trials (RCT) to support its use. Pharmacotherapy and counselling are effective smoking cessation treatments but pharmacotherapy is not used in AC. AC is a behavioural intervention which seems unique.

Primary aim: to determine if AC had higher quit rates than Quit.ie service (Quit.ie is an online portal for smoking cessation) at 3months(mos), secondary aims: quit rates at 1,6, and 12mos. and determining associated factors including weight change.

Methods: Open, single centre, RCT, 300 smokers recruited, 18yrs plus, a minimum 5 cigarettes daily, matched for age, sex and education, were randomly assigned to AC and Quit.ie. Participants with acute cardiac, respiratory, serious psychiatric illnesses, on-going treatment for alcohol/ illicit drugs were excluded. AC consisted of a 5 hour seminar, in a group setting. Self-reported and CO validated quit rates were analysed at 1,3,6, and 12mos.

Results: AC, 151 and Quit.ie, 149 mean age 44 years, outcomes for all 300 were analysed on an Intention to Treat basis.(West et al., 2005) AC had higher quit rates at 1,3,6, and 12mos, AC: 38%(n=57), 27%(n=40), 23%(n=35), 22 %(n=33) vs Quit.ie: 20%(n=30), 15%(n=22), 15%(n=23), 11%(n=17), respectively (all pvalues <0.05) Logistic regression AC vs Quit.ie, OR 2.26 (95% CI 1.22-4.21) pvalue =0.01. Weight gain at 3mos was 3.8kg in AC vs. 1.8kg in Quit.ie (pvalue =0.01). Higher education was associated with quitting in both conditions (pvalue<0.05).

Conclusions: Allen Carr quit rates were superior to Quit.ie, comparable to established interventions, and deserves further evaluation.

Footnotes

Cite this article as: European Respiratory Journal 2018 52: Suppl. 62, OA5227.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2018
Previous
Back to top
Vol 52 Issue suppl 62 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A 12 month smoking cessation outcome-Allen Carr’s Easyway to Stop Smoking-a randomised clinical trial
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
A 12 month smoking cessation outcome-Allen Carr’s Easyway to Stop Smoking-a randomised clinical trial
Sheila Keogan, Shasha Li, Luke Clancy
European Respiratory Journal Sep 2018, 52 (suppl 62) OA5227; DOI: 10.1183/13993003.congress-2018.OA5227

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
A 12 month smoking cessation outcome-Allen Carr’s Easyway to Stop Smoking-a randomised clinical trial
Sheila Keogan, Shasha Li, Luke Clancy
European Respiratory Journal Sep 2018, 52 (suppl 62) OA5227; DOI: 10.1183/13993003.congress-2018.OA5227
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • The effect of parental smoking and smoking inside the house in the adolescents attitude towards smoking
  • Smoking - family structure of origin and other determining factors
  • Tobacco and e-cigarette use, and exposure to SHS among health sciences students: a national cross-sectional study
Show more Tobacco, smoking control and health education

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society